All Posts
Industry GuidesJune 20268 min read

Best AI for Pharma and Biotech in 2026: Research, Writing, and Compliance

How pharmaceutical researchers, regulatory writers, and biotech professionals use AI in 2026 — from literature reviews and protocol drafts to regulatory submissions and medical writing.


Pharmaceutical and biotech teams are adopting AI faster than most industries — because the document burden is enormous and the stakes are high. Regulatory writers, research scientists, medical affairs teams, and clinical operations all have high-leverage AI use cases right now.

Literature Review and Scientific Research

  • PubMed search strategy: AI helps build comprehensive MeSH term combinations and Boolean search strings to maximize literature coverage for systematic reviews
  • Abstract screening: Paste batches of abstracts; AI applies your PICO criteria (Population, Intervention, Comparator, Outcome) to flag relevance, dramatically reducing the time to first pass
  • Synthesis drafts: AI drafts narrative synthesis sections from a set of key papers you provide, flagging conflicting results and evidence quality gaps
  • Competitor intelligence: Use web search-enabled AI to summarize competitor pipeline updates, recent trial results, and FDA decisions in a target indication

Regulatory Writing and Submissions

  • IND narratives: AI drafts investigators' brochure sections, pharmacology summaries, and preclinical overview narratives from structured data you provide
  • Clinical study reports: AI helps write CSR body text sections — study rationale, endpoints justification, and discussion — from your protocol and statistical output
  • FDA correspondence: AI drafts responses to agency information requests (IR letters) using formal regulatory language and structured Q&A format
  • Module 2 summaries: AI drafts Module 2.4 (nonclinical overview) and Module 2.5 (clinical overview) sections from your complete study data, with correct ICH CTD formatting guidance

Clinical Operations and Protocol Writing

  • Protocol drafts: AI generates protocol shells based on your study design, filling in standard ICH E6 sections — objectives, endpoints, eligibility criteria, study schedule — for your team to refine
  • Informed consent forms: AI drafts patient-facing ICF language at an appropriate reading level (8th grade or below) from your protocol scientific text
  • Site documentation: AI drafts site initiation visit agendas, monitoring plans, and deviation response letters in GCP-aligned language
  • Data management plans: AI writes DMP sections covering data collection standards, edit checks, and query management procedures from your study schema

Medical Affairs and Publications

  • Medical information letters: AI drafts off-label scientific exchange letters (SERs) and standard response documents (SRDs) in compliant, factual language
  • Publication planning: AI outlines manuscript structure for original research papers following IMRAD format; drafts Discussion and Conclusion sections from results tables
  • Congress abstract drafts: AI converts your clinical data tables into structured conference abstract drafts within specified word count limits
  • Slide decks: AI generates scientifically accurate slide content with key data points highlighted for advisory board, KOL engagement, and payer meetings

Best Models for Pharma Work

  • Claude Opus 4.8: Best for long regulatory documents — processes 200K token context, excellent instruction-following for complex template constraints, precise scientific language
  • GPT-5 with web search: Best for current competitor intelligence, recent FDA guidance documents, and searching pubmed for recent publications
  • Gemini 2.5 Pro: Strong for very long context tasks — analyzing complete clinical study reports or large protocol packages in one context window
  • Claude Sonnet 4.6: Fast and accurate for drafting standard documents and iterating on regulatory language where speed matters

Important Limitations

  • AI cannot interpret clinical data with the judgment of a licensed physician or biostatistician — always have qualified professionals review outputs
  • AI output must be verified against source data before inclusion in any regulatory submission
  • FDA submissions require human expert review; AI drafts are starting points, not finished documents
  • Check your company's AI acceptable use policy and data governance rules before inputting confidential clinical data into any AI system

Getting Started

bedda.ai Plus gives pharma and biotech professionals Claude Opus 4.8, GPT-5, and Gemini 2.5 Pro for $12/mo — less than most reference database subscriptions. The 200K token context window in Claude is particularly valuable for long regulatory documents. 7-day free trial.


One subscription. 36+ AI models.

Claude Opus 4.8, GPT-5, Gemini 2.5 Pro, Grok 4, and more — starting at $12/month with a 7-day free trial.